Reprogramming the tumour microenvironment by radiotherapy: implications for radiotherapy and immunotherapy combinations

医学 放射治疗 免疫疗法 免疫抑制 肿瘤微环境 免疫系统 肿瘤科 癌症 疾病 髓样 癌症研究 免疫学 内科学
作者
Madyson Colton,Eleanor J. Cheadle,Jamie Honeychurch,Tim Illidge
出处
期刊:Radiation Oncology [BioMed Central]
卷期号:15 (1): 254-254 被引量:96
标识
DOI:10.1186/s13014-020-01678-1
摘要

Radiotherapy (RT) is a highly effective anti-cancer therapy delivered to around 50-60% of patients. It is part of therapy for around 40% of cancer patients who are cured of their disease. Until recently, the focus of this anti-tumour efficacy has been on the direct tumour cytotoxicity and RT-induced DNA damage. Recently, the immunomodulatory effects of RT on the tumour microenvironment have increasingly been recognized. There is now intense interest in potentially using RT to induce an anti-tumour immune response, which has led to rethinking into how the efficacy of RT could be further enhanced. Following the breakthrough of immune check point inhibitors (ICIs), a new era of immuno-oncology (IO) agents has emerged and established immunotherapy as a routine part of cancer treatment. Despite ICI improving outcomes in many cancer types, overall durable responses occur in only a minority of patients. The immunostimulatory effects of RT make combinations with ICI attractive to potentially amplify anti-tumour immunity resulting in increased tumour responses and improved outcomes. In contrast, tumours with profoundly immunosuppressive tumour microenvironments, dominated by myeloid-derived cell populations, remain a greater clinical challenge and RT may potentially further enhance the immunosuppression. To harness the full potential of RT and IO agent combinations, further insights are required to enhance our understanding of the role these immunosuppressive myeloid populations play, how RT influences these populations and how they may be therapeutically manipulated in combination with RT to improve outcomes further. These are exciting times with increasing numbers of IO targets being discovered and IO agents undergoing clinical evaluation. Multidisciplinary research collaborations will be required to establish the optimal parameters for delivering RT (target volume, dose and fractionation) in combination with IO agents, including scheduling to achieve maximal therapeutic efficacy.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
哈士皮发布了新的文献求助10
1秒前
勒言发布了新的文献求助10
1秒前
烧饼发布了新的文献求助10
2秒前
刘帅发布了新的文献求助20
2秒前
n11发布了新的文献求助10
3秒前
754753044发布了新的文献求助10
3秒前
chenqing完成签到,获得积分20
3秒前
SUGATATA的应助被Yoana采纳,获得10
3秒前
wm完成签到,获得积分10
3秒前
现代丸子完成签到 ,获得积分10
4秒前
zhazha完成签到,获得积分10
4秒前
4秒前
5秒前
5秒前
UGO发布了新的文献求助10
5秒前
Elcric完成签到,获得积分10
5秒前
窦向秋完成签到,获得积分20
6秒前
6秒前
深情安青的应助被corleeang采纳,获得10
6秒前
7秒前
7秒前
8秒前
CipherSage的应助被KBBLJL采纳,获得10
8秒前
情怀的应助被陈sir采纳,获得10
8秒前
9秒前
牧百川发布了新的文献求助10
9秒前
grammays发布了新的文献求助10
9秒前
9秒前
FashionBoy的应助被will采纳,获得10
10秒前
杨超肥完成签到,获得积分10
10秒前
senger完成签到 ,获得积分10
11秒前
InaMikan发布了新的文献求助20
11秒前
11秒前
11秒前
wsw111发布了新的文献求助10
11秒前
叶95发布了新的文献求助20
12秒前
拼搏曼易发布了新的文献求助10
12秒前
小蘑菇的应助被yyymmm采纳,获得10
12秒前
科研通AI6.2的应助被DAI采纳,获得10
12秒前
丘比特的应助被Li656943234采纳,获得10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183046
求助须知:如何正确求助?哪些是违规求助? 9572370
关于积分的说明 21824411
捐赠科研通 7779694
什么是DOI,文献DOI怎么找? 3433792
关于科研通互助平台的介绍 2558024
邀请新用户注册赠送积分活动 2479971